Oscotec, 2,028,914 Shares Net Bought by Individuals in Last 5 Days... Stock Price 47,600 KRW (-6.67%)

As of 2:30 PM on the 8th, Oscotec is trading at 47,600 KRW, down 6.67% from the previous day. The trading volume is 2,498,175 shares, which is about 27.97% of the previous day's volume. Oscotec is known as a bio-venture company developing new drugs related to bone tissue.

On January 8th, Kiwoom Securities researcher Heo Hye-min stated, "Disappointing efficacy results from the phase 2a trial of Sevidoplenib. Although the top-line failure of Sevidoplenib caused a sharp drop, 1) the decline in expectations for the new drug candidate has already been reflected, 2) conditional approval of Lazertinib in Korea is expected within January to February, and 3) the top-line announcement for the ITP indication is expected by the end of the year, so the stock price is expected to bottom out. Mid-year, a phase 1 clinical trial application for the AXL inhibitor in Korea is also likely." He set Oscotec's target price at 59,000 KRW.

Over the past five days, individual investors have net bought 2,028,914 shares of Oscotec, while foreigners and institutions have net sold 448,958 shares and 1,574,420 shares, respectively.

※ Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.